Literature DB >> 8423087

Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.

C A Guzman1, G Molinari, M W Fountain, M Rohde, K N Timmis, M J Walker.   

Abstract

Mice were orally vaccinated with liposomes coated with filamentous hemagglutinin (FHA) and detoxified pertussis toxin (PT) of Bordetella pertussis. FHA- and PT-specific immunoglobulin G (IgG) was detected in serum, and both IgG and IgA were detected in lung washes following the immunization. Antibody responses in mice immunized with liposomes coated with FHA and PT were significantly higher than those in mice immunized with free FHA and PT, which demonstrated the adjuvanticity of the liposome carrier. The results indicate the potential usefulness of this approach for eliciting immune responses against FHA and PT (and perhaps other pertussis antigens) in humans and its possible utility in large-scale vaccination to protect against both B. pertussis infection and disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423087      PMCID: PMC302766          DOI: 10.1128/iai.61.2.573-579.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  49 in total

1.  Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization.

Authors:  L P Kahl; C A Scott; R Lelchuk; G Gregoriadis; F Y Liew
Journal:  J Immunol       Date:  1989-06-15       Impact factor: 5.422

2.  Enhancement by lipid A of mucosal immunogenicity of liposome-associated cholera toxin.

Authors:  N F Pierce; J B Sacci; C R Alving; E C Richardson
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

3.  Vaccination of mice with liposome-entrapped adult antigens of Nippostrongylus brasiliensis.

Authors:  A Rhalem; C Bourdieu; G Luffau; P Pery
Journal:  Ann Inst Pasteur Immunol       Date:  1988 Mar-Apr

4.  Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3.

Authors:  H Snippe; J E van Dam; A J van Houte; J M Willers; J P Kamerling; J F Vliegenthart
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

5.  Isolation and characterization of monoclonal antibodies to Bordetella pertussis.

Authors:  D W Frank; C D Parker
Journal:  J Biol Stand       Date:  1984-10

6.  Liposomes, lipid A, and aluminum hydroxide enhance the immune response to a synthetic malaria sporozoite antigen.

Authors:  R L Richards; M D Hayre; W T Hockmeyer; C R Alving
Journal:  Infect Immun       Date:  1988-03       Impact factor: 3.441

7.  Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting.

Authors:  R W Sutter; S L Cochi
Journal:  JAMA       Date:  1992-01-15       Impact factor: 56.272

8.  Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes.

Authors:  D G Russell; J Alexander
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

9.  Location and chemical synthesis of a pre-S gene coded immunodominant epitope of hepatitis B virus.

Authors:  A R Neurath; S B Kent; N Strick
Journal:  Science       Date:  1984-04-27       Impact factor: 47.728

10.  Dissecting human T cell responses against Bordetella species.

Authors:  M T De Magistris; M Romano; S Nuti; R Rappuoli; A Tagliabue
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Is there a role for a mucosal influenza vaccine in the elderly?

Authors:  E M Corrigan; R L Clancy
Journal:  Drugs Aging       Date:  1999-09       Impact factor: 3.923

Review 2.  Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.

Authors:  Dorji Dorji; Frits Mooi; Osvaldo Yantorno; Rajendar Deora; Ross M Graham; Trilochan K Mukkur
Journal:  Med Microbiol Immunol       Date:  2017-11-21       Impact factor: 3.402

3.  Novel polymer-grafted starch microparticles for mucosal delivery of vaccines.

Authors:  P L Heritage; L M Loomes; J Jianxiong; M A Brook; B J Underdown; M R McDermott
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

4.  Coincorporation of LpxL1 and PagL mutant lipopolysaccharides into liposomes with Neisseria meningitidis opacity protein: influence on endotoxic and adjuvant activity.

Authors:  Jesús Arenas; Harry van Dijken; Betsy Kuipers; Hendrik Jan Hamstra; Jan Tommassen; Peter van der Ley
Journal:  Clin Vaccine Immunol       Date:  2010-01-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.